Cytokine-induced reprogramming of human macrophages toward Alzheimer’s disease-relevant molecular and cellular phenotypes in vitro
Open Access
- 25 June 2025
- journal article
- Published by Elsevier in Cell Reports
- Vol. 44 (7) , 115909
Abstract
No abstract availableKeywords
Funding Information
- BrightFocus Foundation
- Alzheimer's Association (24AARF-1191936)
- National Institutes of Health (U01AG058635, R56AG081417, RF1AG054011)
- National Center for Advancing Translational Sciences
- Icahn School of Medicine at Mount Sinai (UL1TR004419)
- New York State Department of Health
- Sanford J. Grossman Charitable Trust
- Freedom Together Foundation
This publication has 87 references indexed in Scilit:
- Early Alzheimer’s disease pathology in human cortex involves transient cell statesCell, 2023
- Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s diseaseActa Neuropathologica, 2021
- Lipid-Associated Macrophages Control Metabolic Homeostasis in a Trem2-Dependent MannerCell, 2019
- Protein Barcodes Enable High-Dimensional Single-Cell CRISPR ScreensCell, 2018
- Disease-Associated Microglia: A Universal Immune Sensor of NeurodegenerationCell, 2018
- TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s DiseaseCell, 2017
- A Unique Microglia Type Associated with Restricting Development of Alzheimer’s DiseaseCell, 2017
- Transcriptional profiling of CD11c-positive microglia accumulating around amyloid plaques in a mouse model for Alzheimer's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2016
- Mast cells mediate neutrophil recruitment during atherosclerotic plaque progressionAtherosclerosis, 2015
- TREM2 regulates microglial cell activation in response to demyelination in vivoActa Neuropathologica, 2015